<DOC>
	<DOCNO>NCT01655628</DOCNO>
	<brief_summary>Nasopharyngeal carcinoma ( NPC ) one common malignant tumor Southern China South Asia . After radiotherapy , patient nasopharyngeal carcinoma still distant metastasis . In recent year , chemotherapeutic agent , gemcitabine , cisplatin , use treat patient advance nasopharyngeal carcinoma , include local recurrence distant metastasis , certain short-term effect . However , chemotherapy alone still ideal effectively improve prognosis patient advance nasopharyngeal carcinoma . Therefore , necessary develop more-effective adjuvant therapy . CIK cell ( cytokine induce killer cell , CIK ) population heterogeneous cell generate vitro amplification mononuclear cell peripheral blood . The cell co-induced multiple cytokine ; lymphocytes co-expression CD3+CD56+ strong anti-tumor effect . Because non-MHC restricted tumor kill activity , CIK cell powerful anti-tumor effect vitro vivo , span broad anti-tumor spectrum . In study , patient post-radiotherapy distant metastasis NPC treat autologous CIK cell combination Gemcitabine plus Cisplatin regimen chemotherapy ( GC ) . The purpose study observe evaluate toxic side effect short- long-term efficacy CIK use combination GC chemotherapy treat NPC patient distant metastasis radiotherapy . Patients Methods : 40 patient distant metastasis radiotherapy accept 4 cycle chemotherapy Gemcitabine plus cisplatin regimen randomize divided 2 group . The 20 patient GC+CIK group treat maintain therapy adoptive autologous CIK cell transfusion sequentially ; 20 patient followed-up without CIK cell treatment . The safety chemotherapy CIK cell transfusion tumor regression status observe . The early response long-term efficacy two group patient accept GC chemotherapy GC +CIK bio-therapy investigate .</brief_summary>
	<brief_title>GC Regimen Chemotherapy Plus CIK Cells Metastatic Nasopharyngeal Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Benzocaine</mesh_term>
	<criteria>1 . The primary lesion patient classify undifferentiated , nonkeratinizing carcinoma initial stage treatment ( WHO , 1991 criterion ) distant metastasis observe base image study radiotherapy ; 2. patient received standard dos radiotherapy , regularly followedup radiotherapy , distant metastatic lesion reveal image study ; 3. metastasis find 6 month end radiotherapy , expect survival time 3 month ; 4. case , 10 metastatic lesion find image study ; 5 . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 ; 6. bone marrow function normally ( WBC &gt; 4.0×109/L , Hb &gt; 120 g/L , PLT &gt; 100×109/L ) ; 7. ECG result normal , liver kidney functional . 1 . Patients excluded central nervous system metastases ; 2. uncontrolled infection ; underlying disease severe lifethreatening ; 3. patient pregnant lactating ; 4 . ECOG perform status ≥ 2 ; 5. patient suffer auto immune diseases patient need accept glucocorticoid treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>nasopharyngeal carcinoma</keyword>
	<keyword>metastasis</keyword>
	<keyword>gemcitabine</keyword>
	<keyword>CIK cell</keyword>
</DOC>